Theratechnologies Inc. (THTX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
THTX currently has 46M outstanding shares. with minimal authorized share overhang for future dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Feb 26, 2025 |
20-F filing | 46.0M shares outstanding |
46M | 0 |
| Feb 21, 2024 |
20-F filing | 46.0M shares outstanding |
46M | 0 |
| Dec 21, 2023 |
F-3 filing: The filing is an F-3 registration statement for a shelf offering of common shares, preferred shares, subscription receipts, warrants, debt securities and units, up to a total value of US$100,000,000. |
97M | 0 |
| Feb 28, 2023 |
40-F filing | 96.8M shares outstanding |
97M | 0 |
| Feb 24, 2022 |
40-F filing | 95.1M shares outstanding |
95M | 0 |
| Nov 23, 2021 |
F-10 filing: The filing is an F-10 form, which is a prospectus prepared in accordance with Canadian disclosure requirements under the MJDS system. It relates to the potential offering of various securities including Preferred Shares, Subscription Receipts, Warrants, Debt Securities, and Units. The specific terms of any offering will be detailed in a Prospectus Supplement. |
77M | 0 |
| Feb 25, 2021 |
40-F filing | 77.0M shares outstanding |
77M | 0 |
| Feb 25, 2020 |
40-F filing | 77.0M shares outstanding |
77M | 0 |